id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-4815-0001,FDA,FDA-2024-N-4815,Patient-Focused Drug Development: Workshop To Discuss Methodologic and Other Challenges Related to Patient Experience Data; Public Workshop; Request for Comments,Notice,Request for Comments,2024-11-14T05:00:00Z,2024,11,2024-11-14T05:00:00Z,2025-02-12T04:59:59Z,2025-02-12T02:00:33Z,2024-26399,0,0,0900006486815282